Ever since the recent decision of the Supreme Court limiting the use of race in drawing congressional districts, there has ...
Lorem has an excellent safety and tolerability profile across 50 nano-rare patients treated with personalized ASO medicines.
n-Lorem, a nonprofit foundation, announced today that the 50 th nano-rare patient has been treated with a personalized, experimental antisense oligonucleotide (ASO) medicine discovered, developed and ...
Susannah Rosen was diagnosed with a KIF1A gene mutation at the age of 2½. Patients diagnosed with severe KIF1A gene mutations may live only into early childhood, while patients with mild symptoms can ...
SAN DIEGO and GENEVA, Jan. 13, 2026 /PRNewswire/ -- The n-Lorem Foundation and the EspeRare Foundation announced today a strategic collaboration to expand access in Europe to n-Lorem's antisense ...
Stanley Crooke, Ionis Pharmaceuticals founder and n-Lorem founder, joins 'Squawk Box' to discuss the fight against rare diseases, the development of ASO technology, and more. Got a confidential news ...
AI-generated summary reviewed by our newsroom. Read our AI Policy. Cheers, Charlotte! The city now has the bragging rights of being home to one of the best bars in the country. Esquire dropped its ...
Daniel Ek, founder and CEO of Spotify, in a file photo. Spotify has all the world’s music… in theory. But its algorithms decide many things. Like other technology platforms, Spotify makes decisions to ...
Five years ago, the n-Lorem Foundation set out on a mission to provide free, lifetime ASO treatments for nano-rare patients. Today, we've made remarkable strides forming a united nano-rare community ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results